by James on 1 December 2005
MT 100, an oral migraine drug from Pozen, was been approved in the UK on Monday (28 Nov). The drug contains naproxen sodium and metoclopramide. Naproxen sodium is familiar to migraineurs, it reduces pain and inflammation, and is often used for migraine brought on by hormonal changes. Metoclopramide has been used to reduce pain and [...]
by James on 6 August 2005
Pozen, Inc. has decided to stop developing its new migraine drug, MT 100. The Naproxen Sodium and Metoclopramide Hydrochloride drug needed more trials, the FDA concluded. There have been concerns that it may cause tardive dyskinesia, a chronic disorder of the nervous system causing jerky movements in the face, tongue, and other parts of the [...]